These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8100486)

  • 41. Infection of human natural killer (NK) cells with replication-defective human T cell leukemia virus type I provirus. Increased proliferative capacity and prolonged survival of functionally competent NK cells.
    Lo KM; Vivier E; Rochet N; Dehni G; Levine H; Haseltine WA; Anderson P
    J Immunol; 1992 Dec; 149(12):4101-8. PubMed ID: 1460293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of HTLV-1 HBZ and proviral load, together with host IFN λ3, in pathogenesis of HAM/TSP.
    Mozhgani SH; Jaberi N; Rezaee SA; Bustani R; Jazayeri SM; Akbarin MM; Milani S; Tarokhian H; Norouzi M
    J Med Virol; 2017 Jun; 89(6):1102-1107. PubMed ID: 27787900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive and Negative Regulation of Type I Interferons by the Human T Cell Leukemia Virus Antisense Protein HBZ.
    Narulla MS; Alsairi A; Charmier L; Noonan S; Conroy D; Hall WW; Sheehy N
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. IL-10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte-derived TNF-alpha and guarantee asymptomatic clinical status during chronic HTLV-I infection.
    Brito-Melo GE; Peruhype-Magalhães V; Teixeira-Carvalho A; Barbosa-Stancioli EF; Carneiro-Proietti AB; Catalan-Soares B; Ribas JG; ; Martins-Filho OA
    Clin Exp Immunol; 2007 Jan; 147(1):35-44. PubMed ID: 17177961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concomitant augmentation of CD4+ CD29+ helper inducer and diminution of CD4+ CD45RA+ suppressor inducer subset in patients infected with human T cell lymphotropic virus types I or II.
    Lal RB; Rudolph DL; Schmid DS; Lairmore MD
    Clin Exp Immunol; 1992 Feb; 87(2):293-7. PubMed ID: 1370929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriers.
    Coutinho R; Grassi MF; Korngold AB; Olavarria VN; Galvão-Castro B; Mascarenhas RE
    BMC Infect Dis; 2014 Aug; 14():453. PubMed ID: 25148903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Virological and immunological mechanisms in the pathogenesis of human T-cell leukemia virus type 1.
    Satou Y; Matsuoka M
    Rev Med Virol; 2013 Sep; 23(5):269-80. PubMed ID: 23606621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes.
    Hanon E; Hall S; Taylor GP; Saito M; Davis R; Tanaka Y; Usuku K; Osame M; Weber JN; Bangham CR
    Blood; 2000 Feb; 95(4):1386-92. PubMed ID: 10666215
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection.
    Mulherkar R; Karabudak A; Ginwala R; Huang X; Rowan A; Philip R; Murphy EL; Clements D; Ndhlovu LC; Khan ZK; Jain P
    Vaccine; 2018 Aug; 36(33):5046-5057. PubMed ID: 30005946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Kubota R; Jacobson S
    J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Michaëlsson J; Barbosa HM; Jordan KA; Chapman JM; Brunialti MK; Neto WK; Nukui Y; Sabino EC; Chieia MA; Oliveira AS; Nixon DF; Kallas EG
    BMC Immunol; 2008 Jul; 9():41. PubMed ID: 18664281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prophylaxis against a Melanesian variant of human T-lymphotropic virus type I (HTLV-I) in rabbits using HTLV-I immune globulin from asymptomatically infected Japanese carriers.
    Tanaka Y; Ishii K; Sawada T; Ohtsuki Y; Hoshino H; Yanagihara R; Miyoshi I
    Blood; 1993 Dec; 82(12):3664-7. PubMed ID: 8260703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cell-mediated immune response to human T-lymphotropic virus type I.
    Mosley AJ; Asquith B; Bangham CR
    Viral Immunol; 2005; 18(2):293-305. PubMed ID: 16035941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
    Wilson AD; Morgan AJ
    J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro cellular tropism of human T cell leukemia virus type 2.
    Wang TG; Ye J; Lairmore MD; Green PL
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1661-8. PubMed ID: 11080807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HTLV-1-infected thymic epithelial cells convey the virus to CD4
    Carvalho Barros LR; Linhares-Lacerda L; Moreira-Ramos K; Ribeiro-Alves M; Machado Motta MC; Bou-Habib DC; Savino W
    Immunobiology; 2017 Dec; 222(12):1053-1063. PubMed ID: 28888743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HTLV-I-infected T cells evade the antiproliferative action of IFN-beta.
    Smith D; Buckle GJ; Hafler DA; Frank DA; Höllsberg P
    Virology; 1999 May; 257(2):314-21. PubMed ID: 10329542
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells: implications for in vivo coinfection with HTLV-I and HIV-1.
    Moriuchi H; Moriuchi M; Fauci AS
    J Exp Med; 1998 May; 187(10):1689-97. PubMed ID: 9584147
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The efficacy of combined therapy of arsenic trioxide and alpha interferon in human T-cell leukemia virus type-1-infected squirrel monkeys (Saimiri sciureus).
    Heraud JM; Mortreux F; Merien F; Contamin H; Mahieux R; Pouliquen JF; Wattel E; Gessain A; de Thé H; Bazarbachi A; Hermine O; Kazanji M
    Antiviral Res; 2006 Jul; 70(3):132-9. PubMed ID: 16540180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.